Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People with active ulcerative colitis (UC), measured using a scoring system called the Mayo score, with a score above 3
- People whose UC affects the lining of the bowel, confirmed by a score above 0 on the endoscopic part of the Mayo scoring system
- Women who are able to become pregnant and are willing and able to use an acceptable form of contraception as outlined by Health Canada guidelines
Who may not be able to join:
- People who are currently taking part in another clinical trial for UC
- People who are unable to give informed consent
- People with serious other medical conditions
- People whose UC is severe enough to require a hospital stay
- People whose UC medications have been increased or changed in the past 12 weeks (note: continuing stable doses of certain medications — such as 5-ASA, azathioprine, 6-mercaptopurine, or anti-TNF treatments like infliximab — may be permitted if the dose has been unchanged for at least 12 weeks; confirm with trial site)
- People who have taken antibiotics in the last 30 days
- People who are pregnant
- People with significant liver problems at the time of screening, based on a specific liver enzyme (ALT) blood test result (confirm with trial site)
- People with significant kidney problems at the time of screening, based on a specific kidney function blood test result (confirm with trial site)
- People where, in the opinion of the trial doctor, participation could pose a health risk
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paul Moayyedi, MD, HHSC/McMaster
Phone: 9055212100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of FMT donors at inducing UC remission; Efficacy of FMT at maintaining remission in UC
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.